468 related articles for article (PubMed ID: 17532515)
1. Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
Bishop AC; Zhang XY; Lone AM
Methods; 2007 Jul; 42(3):278-88. PubMed ID: 17532515
[TBL] [Abstract][Full Text] [Related]
2. Allele-specific inhibitors of protein tyrosine phosphatases.
Hoffman HE; Blair ER; Johndrow JE; Bishop AC
J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
[TBL] [Abstract][Full Text] [Related]
3. A gatekeeper residue for inhibitor sensitization of protein tyrosine phosphatases.
Bishop AC; Blair ER
Bioorg Med Chem Lett; 2006 Aug; 16(15):4002-6. PubMed ID: 16716588
[TBL] [Abstract][Full Text] [Related]
4. Rational design of allosteric-inhibition sites in classical protein tyrosine phosphatases.
Chio CM; Yu X; Bishop AC
Bioorg Med Chem; 2015 Jun; 23(12):2828-38. PubMed ID: 25828055
[TBL] [Abstract][Full Text] [Related]
5. Probing the molecular basis for potent and selective protein-tyrosine phosphatase 1B inhibition.
Guo XL; Shen K; Wang F; Lawrence DS; Zhang ZY
J Biol Chem; 2002 Oct; 277(43):41014-22. PubMed ID: 12193602
[TBL] [Abstract][Full Text] [Related]
6. Engineering non-natural inhibitor sensitivity in protein tyrosine phosphatase H1.
Blair ER; Hoffman HE; Bishop AC
Bioorg Med Chem; 2006 Jan; 14(2):464-71. PubMed ID: 16182535
[TBL] [Abstract][Full Text] [Related]
7. Allele-specific inhibition of divergent protein tyrosine phosphatases with a single small molecule.
Zhang XY; Chen VL; Rosen MS; Blair ER; Lone AM; Bishop AC
Bioorg Med Chem; 2008 Sep; 16(17):8090-7. PubMed ID: 18678493
[TBL] [Abstract][Full Text] [Related]
8. Optimized allosteric inhibition of engineered protein tyrosine phosphatases with an expanded palette of biarsenical small molecules.
Korntner S; Pomorski A; Krężel A; Bishop AC
Bioorg Med Chem; 2018 May; 26(9):2610-2620. PubMed ID: 29673715
[TBL] [Abstract][Full Text] [Related]
9. Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases.
Zhang ZY
Acc Chem Res; 2017 Jan; 50(1):122-129. PubMed ID: 27977138
[TBL] [Abstract][Full Text] [Related]
10. A novel strategy for the development of selective active-site inhibitors of the protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and phogrin (IA-2beta).
Drake PG; Peters GH; Andersen HS; Hendriks W; Møller NP
Biochem J; 2003 Jul; 373(Pt 2):393-401. PubMed ID: 12697028
[TBL] [Abstract][Full Text] [Related]
11. Functional studies of protein tyrosine phosphatases with chemical approaches.
Zhang ZY
Biochim Biophys Acta; 2005 Dec; 1754(1-2):100-7. PubMed ID: 16226063
[TBL] [Abstract][Full Text] [Related]
12. Residue 182 influences the second step of protein-tyrosine phosphatase-mediated catalysis.
Pedersen AK; Guo XL; Møller KB; Peters GH; Andersen HS; Kastrup JS; Mortensen SB; Iversen LF; Zhang ZY; Møller NP
Biochem J; 2004 Mar; 378(Pt 2):421-33. PubMed ID: 14572311
[TBL] [Abstract][Full Text] [Related]
13. Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatases.
Iversen LF; Andersen HS; Møller KB; Olsen OH; Peters GH; Branner S; Mortensen SB; Hansen TK; Lau J; Ge Y; Holsworth DD; Newman MJ; Hundahl Møller NP
Biochemistry; 2001 Dec; 40(49):14812-20. PubMed ID: 11732900
[TBL] [Abstract][Full Text] [Related]
14. Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.
Burke TR; Zhang ZY
Biopolymers; 1998; 47(3):225-41. PubMed ID: 9817026
[TBL] [Abstract][Full Text] [Related]
15. Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.
Stuible M; Zhao L; Aubry I; Schmidt-Arras D; Böhmer FD; Li CJ; Tremblay ML
Chembiochem; 2007 Jan; 8(2):179-86. PubMed ID: 17191286
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of protein tyrosine phosphatase non-receptor type 2 by PTP inhibitor XIX: Its role as a multiphosphatase inhibitor.
Le HTT; Cho YC; Cho S
BMB Rep; 2017 Jun; 50(6):329-334. PubMed ID: 28228214
[TBL] [Abstract][Full Text] [Related]
17. Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.
Zhang ZY
Annu Rev Pharmacol Toxicol; 2002; 42():209-34. PubMed ID: 11807171
[TBL] [Abstract][Full Text] [Related]
18. Drug discovery and protein tyrosine phosphatases.
Blaskovich MA
Curr Med Chem; 2009; 16(17):2095-176. PubMed ID: 19519384
[TBL] [Abstract][Full Text] [Related]
19. Dynamic substrate enhancement for the identification of specific, second-site-binding fragments targeting a set of protein tyrosine phosphatases.
Schmidt MF; Groves MR; Rademann J
Chembiochem; 2011 Nov; 12(17):2640-6. PubMed ID: 22052725
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for inhibition of protein tyrosine phosphatases by Keggin compounds phosphomolybdate and phosphotungstate.
Heo YS; Ryu JM; Park SM; Park JH; Lee HC; Hwang KY; Kim J
Exp Mol Med; 2002 Jul; 34(3):211-23. PubMed ID: 12216113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
